Ferrous bisglycinate is a form of iron supplement in which an iron atom is bonded to two molecules of glycine, the smallest amino acid. This chelated structure sets it apart from more common iron supplements like ferrous sulfate, and it has gained popularity for its higher bioavailability and reputation for being easier on the stomach. You’ll find it listed on supplement labels as “iron bisglycinate,” “iron bisglycinate chelate,” or sometimes just “chelated iron.”
How It Differs From Regular Iron Supplements
Most traditional iron supplements use iron salts, with ferrous sulfate being the most widely prescribed. In these forms, iron exists as a free ion that must compete with other minerals and compounds in your digestive tract for absorption. Ferrous bisglycinate works differently. The two glycine molecules wrap around the iron atom, forming a protective chelate ring. This structure keeps the iron shielded as it moves through your stomach and into your small intestine, which reduces its interaction with food components and the gut lining.
The practical result is that ferrous bisglycinate can be effective at lower doses. In clinical trials, doses as low as 15 to 30 mg of elemental iron daily have been used successfully, while ferrous sulfate trials often use 80 to 120 mg. A randomized controlled trial in Mexican schoolchildren found that after six months of supplementation, the bisglycinate group had ferritin levels (a marker of iron stores) roughly 6 µg/L higher than the ferrous sulfate group, even at comparable doses. That gap widened over time, suggesting the chelated form builds iron stores more efficiently with sustained use.
How Your Body Absorbs It
There was an early theory that ferrous bisglycinate might sneak into intestinal cells through a completely different doorway than regular iron, specifically through a peptide transporter called PepT1, the same channel your gut uses to absorb small protein fragments. If true, this would mean the chelated iron could bypass the usual bottlenecks of iron absorption entirely.
The reality turns out to be more nuanced. Research using human intestinal cells with the main iron transporter (DMT1) knocked out found that iron absorption dropped dramatically for both ferrous bisglycinate and ferrous sulfate. This strongly suggests ferrous bisglycinate relies on the same primary transporter as regular iron. The expression of PepT1 didn’t change between the two iron forms, weakening the alternative-pathway theory. However, a backup transporter called Zip14 appears to play a small supporting role, which may give bisglycinate a slight edge when the primary pathway is saturated.
So the absorption advantage of ferrous bisglycinate likely comes not from using a different door into your cells, but from the glycine shell protecting the iron from being bound up by other compounds in the gut before it ever reaches that door. Free iron from ferrous sulfate is highly reactive and readily binds to phytates in grains, tannins in tea, and other dietary inhibitors, which reduces how much actually makes it to the intestinal wall. The chelate structure minimizes this interference.
Digestive Side Effects
The most common complaint about iron supplements is that they’re hard on the gut. Nausea, constipation, cramping, and dark stools are familiar side effects for anyone who has taken ferrous sulfate. These problems happen because free iron ions irritate the lining of the digestive tract and alter gut bacteria.
Ferrous bisglycinate generally causes fewer of these issues. Because the iron is wrapped in glycine, less of it is exposed to the gut lining in its free, reactive form. The European Food Safety Authority has established that iron intake up to 40 mg per day from diet and supplements combined is unlikely to cause adverse effects like black stools in adults. Since ferrous bisglycinate is typically dosed at the lower end of the range (often 15 to 30 mg of elemental iron), many people find they can take it without the side effects that made them quit ferrous sulfate. That said, higher doses of any iron form will increase the likelihood of stomach upset.
Who Benefits Most
Ferrous bisglycinate has been studied across a range of groups: children, adolescents, nonpregnant women, pregnant women, and cancer patients receiving treatment. The consistent finding is that it raises hemoglobin and ferritin levels effectively.
Pregnant women are one group where this form shows particular promise. A randomized controlled trial comparing ferrous bisglycinate (combined with folinic acid) to a standard iron supplement found that both groups saw significant improvements in hemoglobin, ferritin, and other red blood cell markers at three and six months. But the bisglycinate group consistently showed larger improvements at every time point. For a population that needs reliable iron absorption and often struggles with nausea from supplements, a lower-dose, better-tolerated option has obvious appeal.
Clinical trials in children have used doses ranging from 3 mg of elemental iron per kilogram of body weight up to 30 mg daily. For adults, study doses have ranged from 15 mg once daily to 60 mg twice daily, though the majority of trials used 15 to 30 mg. Cancer patients in one trial took just 28 mg of ferrous bisglycinate daily compared to 105 mg of ferrous sulfate, reflecting the principle that less chelated iron can do the work of more conventional iron.
Safety and Regulatory Status
The European Food Safety Authority evaluated ferrous bisglycinate in 2006 and concluded it was of no safety concern when used as a nutritional supplement under proposed conditions. It sits alongside other approved iron sources like ferrous phosphate and iron taurate.
EFSA’s most recent assessment on iron intake overall set safe daily levels at 40 mg for adults, pregnant women, and lactating women. For children, the safe levels are lower: 10 mg per day for ages 1 to 3, scaling up to 35 mg for ages 15 to 17. These numbers refer to total iron intake from food, fortified products, and supplements combined. Notably, EFSA was unable to establish a formal upper tolerable limit for iron because the dose-response data for toxicity isn’t clean enough to draw a precise line. The 40 mg figure is a practical safe level, not a toxicity threshold.
Choosing Ferrous Bisglycinate
When shopping for this supplement, pay attention to how the label reports the dose. Some brands list the total weight of the ferrous bisglycinate compound, while others list only the elemental iron it delivers. The elemental iron number is what matters, because that’s the amount of actual iron your body can use. A capsule labeled “325 mg ferrous bisglycinate” may contain only 25 to 45 mg of elemental iron, depending on the formulation. Roughly 20% of the chelate’s weight is elemental iron, though this varies slightly between manufacturers.
For most people supplementing a mild deficiency, 15 to 30 mg of elemental iron from ferrous bisglycinate taken once daily is the range supported by the majority of clinical trials. Taking it on an empty stomach improves absorption, though the chelated form is more forgiving than ferrous sulfate if you need to take it with food to avoid discomfort. The glycine shell offers some built-in protection against common dietary absorption blockers, giving you more flexibility in timing around meals.